A clinical trial at Sunnybrook Hospital in Toronto will determine the effectiveness of a targeted radiotherapy approach, stereotactic body radiotherapy (SBRT), in improving outcomes for men with oligometastatic prostate cancer.
A clinical trial at Sunnybrook Hospital in Toronto will determine the effectiveness of a targeted radiotherapy approach, stereotactic body radiotherapy (SBRT), in improving outcomes for men with oligometastatic prostate cancer.